# Atropos Health

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/atropos-health

- Industry: Healthcare IT
- Headquarters: New York, US
- Website: www.atroposhealth.com
- Total disclosed funding: $44M
- Latest round: Series B (May 20, 2024)
- Investors on record: 11

## About

Based in New York, US, and founded in 2020, by co-founders Brigham Hyde, Nigam Shah, and Saurabh Gombar, Atropos Health, Inc., aka Atropos Health, Atropos operates as a health-tech company that provides digital consultation services to help physicians answer clinical questions using real-world clinical and administrative data. In May 2024, Atropos Health Inc. raised USD 33 million in series B funding led by new investor Valtruis, with participation from returning investors Breyer Capital, Emerson Collective, and Presidio Ventures. New investors Cencora Ventures, McKesson Ventures, and Merck Global Health Innovation Fund also participated in the round.

The company offers a green button and evidence portal solutions through which the patients get a reply to the question within 48 hrs. The company's platform leverages electronic medical record (EMR) data to derive digital evidence for individual patients and allows healthcare institutions to create value from previously siloed EMR data.

The company will use the May 2024 funding to support its expansion.

## Funding rounds

- Series B, May 20, 2024, $33M — Merck Global Health Innovation Fund, Presidio Ventures, Breyer Capital, McKesson Ventures, Valtruis, Cencora Ventures, Emerson Collective
- Series A, Jul 28, 2023, $3.3M — Presidio Ventures, Audere Capital, Gaingels, Samsung NEXT Ventures
- Series A, Aug 4, 2022, $8M — Boston Millennia Partners, Breyer Capital, Emerson Collective

## Investors

- Boston Millennia Partners (https://capitalatlas.ai/funds/boston-millennia-partners) — Series A
- Breyer Capital (https://capitalatlas.ai/funds/breyer-capital) — Series A, Series B
- Emerson Collective — Series A, Series B
- Presidio Ventures (https://capitalatlas.ai/funds/presidio-ventures) — Series A, Series B
- Audere Capital (https://capitalatlas.ai/funds/audere-capital) — Series A
- Gaingels (https://capitalatlas.ai/funds/gaingels) — Series A
- Samsung NEXT Ventures (https://capitalatlas.ai/funds/samsung-next-ventures) — Series A
- Merck Global Health Innovation Fund (https://capitalatlas.ai/funds/merck-global-health-innovation-fund) — Series B
- McKesson Ventures (https://capitalatlas.ai/funds/mckesson-ventures) — Series B
- Valtruis — Series B
- Cencora Ventures (https://capitalatlas.ai/funds/cencora-ventures) — Series B